Explore
Validate
LearnPA1760
antibody from Boster Biological Technology
Targeting: CXCL1
FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA1760 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-GRO alpha/CXCL1 Antibody
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for GRO alpha/CXCL1 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: WB. Reactive species: Human. GRO alpha/CXCL1 information: Molecular Weight: 11301 MW; Subcellular Localization: Secreted.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Induction of mesenchymal stem cell differentiation in the absence of soluble inducer for cutaneous wound regeneration by a chitin nanofiber-based hydrogel.
Chemokine receptor CXCR2 in dorsal root ganglion contributes to the maintenance of inflammatory pain.
JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1.
Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2.
Shou K, Huang Y, Qi B, Hu X, Ma Z, Lu A, Jian C, Zhang L, Yu A
Journal of tissue engineering and regenerative medicine 2018 Feb;12(2):e867-e880
Journal of tissue engineering and regenerative medicine 2018 Feb;12(2):e867-e880
Chemokine receptor CXCR2 in dorsal root ganglion contributes to the maintenance of inflammatory pain.
Cao DL, Qian B, Zhang ZJ, Gao YJ, Wu XB
Brain research bulletin 2016 Oct;127:219-225
Brain research bulletin 2016 Oct;127:219-225
JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1.
Wang ZL, Du TT, Zhang RG
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2016 Feb;36(1):88-94
Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2016 Feb;36(1):88-94
Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2.
Cao DL, Zhang ZJ, Xie RG, Jiang BC, Ji RR, Gao YJ
Experimental neurology 2014 Nov;261:328-36
Experimental neurology 2014 Nov;261:328-36
No comments: Submit comment
No validations: Submit validation data